← Back to dossier
Patient handout

Acute OCD (Severe / Treatment-Resistant Exacerbation) — ED/inpatient acute stabilization + SRI high-dose + clomipramine adjunct + AP augmentation + ERP referral (APA OCD 2023; NICE CG31 2024; IOCDF 2025; PANS Consortium 2017 PMID 28859386)

PRODUCTION

1. Your condition

This handout is for acute ocd (severe / treatment-resistant exacerbation) — ed/inpatient acute stabilization + sri high-dose + clomipramine adjunct + ap augmentation + erp referral (apa ocd 2023; nice cg31 2024; iocdf 2025; pans consortium 2017 pmid 28859386). Your care team identified this based on: y-bocs ≥30 sudden surge — extreme severity band (y-bocs 32-40) or severe band (24-31) with rapid escalation (goodman arch gen psych 1989 pmid 2684084; apa ocd 2023).

Other reasons your team may use this plan: dehydration from compulsive hand-washing / contamination rituals; severe dermatitis; refusal of food/water due to contamination obsession; functional collapse — inability to perform adls (apa ocd 2023; iocdf 2025); active si with plan / intent / means in ocd — ego-dystonic intrusions can drive suicidality especially in treatment-resistant cases (c-ssrs positive; posner ajp 2011 pmid 22193671); pediatric / adolescent abrupt onset ocd + tics + emotional lability + sleep disturbance + handwriting deterioration + cognitive change post-streptococcal infection — pandas / pans (frankovich jcap 2017 pmid 28859386; pans consortium 2017 + 2024 update).

2. Your medications

Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.

MedicationStarting doseHowWhenWhat it does
IV fluid resuscitationNS or LR 1-2 L bolus → maintenance 75-125 mL/hr titrated to UOPIVcontinuous until rehydratedSevere compulsions producing medical harm — refusal of water due to contamination obsession or excessive hand-washing rituals leading to dehydration require IVF + electrolyte correction before further OCD pharmacotherapy (APA OCD 2023; IOCDF 2025)
nutritional support order setCalorie + protein targets per dietitian; NG tube if persistent refusal; psychiatric oversight of forced feeding ethicsPO/NGq meal with monitoringSevere contamination obsession with food refusal causing nutritional decompensation — dietitian + psych co-management; refeeding syndrome risk if prolonged starvation (cross-ref workup.refeeding; ESPEN 2020)
1:1 sitter + suicide precautionsContinuous 1:1 observation while active SI present; means restriction (lock-box for meds, firearm restriction per Stanley-Brown 2012)NAcontinuousActive SI in severe OCD requires continuous observation + means restriction; Stanley-Brown safety plan documented; cross-route psych.suicidality.ed.core.v1 (Mann JAMA 2005; Stanley-Brown 2012; VA/DoD 2022)
lorazepam0.5-1 mg PO / SL / IM PRN for severe agitation or anxiety during stabilization; short-term onlyPO/SL/IMPRN q 4-6 h short-termShort-term anxiolytic bridge only (<4-6 weeks); NEVER long-term monotherapy in OCD — does not treat obsessions / compulsions; AVOID with opioids (FDA 2016 black-box); AVOID in elderly (Beers 2023); preferred in hepatic disease over diazepam (APA OCD 2023; IOCDF 2025)

Plan: Acute OCD stabilization — IVF if dehydrated, food/water support, suicide precautions, 1:1 sitter (APA OCD 2023; IOCDF 2025)

3. Your action plan

Use these zones to know what to do based on how you feel.

GREENDoing well — Y-BOCS <14, sustained response, functioning at baseline, no acute medical complications of rituals (APA OCD 2023)
If you have:
  • Y-BOCS sustained <14 (remission per APA OCD 2023)
  • No suicidal thoughts (C-SSRS; Posner 2011)
  • Engaging with usual activities and relationships (APA OCD 2023)
  • ERP homework + maintenance sessions occurring (IOCDF 2025)
Do this:
  • Take SRI / clomipramine as prescribed every day — do not stop suddenly (APA OCD 2023)
  • Continue ERP maintenance sessions q month + practice exposures daily (IOCDF 2025)
  • Continue family accommodation reduction practices (IOCDF 2025)
  • Keep follow-up appointments (APA OCD 2023)
  • Keep crisis line numbers available (VA/DoD 2022)
YELLOWCaution — Y-BOCS rising, return of rituals, family accommodation creeping back, passive SI (APA OCD 2023; IOCDF 2025)
If you have:
  • Rituals returning or increasing duration (APA OCD 2023)
  • Avoidance behaviour increasing (APA OCD 2023)
  • Family accommodation increasing (IOCDF 2025)
  • Passing thoughts that life is not worth living without intent or plan (C-SSRS; Posner 2011)
  • Increased alcohol or substance use (VA/DoD 2022)
  • Withdrawal from supports (APA OCD 2023)
Do this:
  • Use coping strategies from your safety plan — call ERP therapist, contact support person, return to recent exposure exercises (Stanley-Brown 2012; IOCDF 2025)
  • Contact your provider for an early appointment — within 1 week (APA OCD 2023)
  • Review SRI adherence + dose adequacy with provider (APA OCD 2023)
  • Family accommodation review session with therapist (IOCDF 2025)
  • Avoid means of self-harm — lock or remove firearms; secure or limit medications to short supply (especially TCAs; VA/DoD 2022)
Call your provider if:
  • Symptoms not improving after 1-2 weeks of self-care (APA OCD 2023)
  • Y-BOCS rises by ≥5 points (Goodman 1989)
  • Any thoughts of suicide become more frequent (VA/DoD 2022)
  • Functioning at work / home declines (APA OCD 2023)
REDMedical alert — active SI with intent / plan / means, dehydration / refusal of food-water from rituals, catatonia, postpartum psychosis, pediatric PANS acute worsening (APA OCD 2023; VA/DoD 2022; PANS Consortium 2017)
If you have:
  • Specific thoughts of how to end your life (C-SSRS; Posner 2011)
  • Access to means — firearms, large-quantity meds (especially TCAs; VA/DoD 2022)
  • Recent self-harm or attempt (APA OCD 2023)
  • Dehydration / refusal of food / water from rituals (APA OCD 2023)
  • Mutism / immobility / waxy flexibility — catatonia overlay (Sienaert 2014)
  • Postpartum with intrusive harm-of-infant obsessions OR reality-testing failure (APA OCD 2023; cross-ref psych.postpartum-psychosis.v1)
  • Pediatric — acute neuropsychiatric worsening + tics + autonomic features post-infection (PANS Consortium 2017 PMID 28859386)
Do this:
  • Call 988 (US) / your local crisis line / emergency services NOW (VA/DoD 2022)
  • Go to the nearest emergency department; do not be alone (APA OCD 2023)
  • Hand any means (firearms, TCAs / pills) to a trusted person before going (VA/DoD 2022)
  • Tell someone you trust what is happening (Stanley-Brown 2012)
  • Do not use alcohol or non-prescribed substances (APA OCD 2023)
  • Pediatric — caregivers contact pediatrician + go to ED if acute autoimmune neurologic features (PANS Consortium 2017)
Call your provider if:
  • Any red zone trigger — emergency department immediately, do not wait (APA OCD 2023; VA/DoD 2022)

4. When to seek emergency care

Call 911 or go to the nearest emergency room right away if you have:

  • Y-BOCS ≥30 sudden surge — extreme band (32-40) or severe band (24-31) with rapid escalation; functional collapse with inability to perform ADLs
  • C-SSRS positive for active SI with intent / plan / preparatory behaviour in severe OCD — TCA / clomipramine overdose lethality elevates means-restriction priority(life-threatening)
  • Severe dehydration / electrolyte derangement from compulsive hand-washing; severe dermatitis; refusal of food/water due to contamination obsession leading to nutritional decompensation
  • Catatonic features (mutism / immobility / waxy flexibility / negativism / posturing) overlaying severe / refractory OCD — BFCSI ≥ 2 features
  • OCD or psychotic features (delusions / hallucinations / reality-testing failure / infanticidal ideation) with onset within 1 year of delivery; postpartum OCD typically ego-dystonic intrusions of harm to infant — distinct from postpartum psychosis with reality-testing failure
  • Pediatric / adolescent abrupt onset OCD + tics + emotional lability + sleep disturbance + handwriting deterioration + cognitive change post-streptococcal infection (PANDAS) OR post-any-infection (broader PANS criteria)
  • Treatment-resistant OCD = failure of ≥ 2 adequate SRI trials at adequate dose × 10-12 weeks each (longer than MDD adequate trial); pseudo-resistance (subtherapeutic dose / inadequate duration / non-adherence / unrecognized comorbidity / medical mimic) must be ruled out FIRST
  • Tremor, hyperreflexia, clonus, hyperthermia, autonomic instability, AMS in patient on SSRI + clomipramine combination — Hunter / Sternbach criteria; risk especially elevated with fluvoxamine + clomipramine (CYP1A2 + CYP2C19 → 6-fold clomipramine level rise)(life-threatening)

5. Follow-up

SRI maintenance ≥ 1-2 years post-remission for first episode; longer or indefinite if recurrent / treatment-resistant (APA OCD 2023; IOCDF 2025); ERP weekly × 12-20 sessions then maintenance q month; intensive outpatient ERP 4-5×/week for treatment-resistant cases (IOCDF 2025); AP augmentation review q 6 mo (metabolic + EPS + AIMS); PANDAS / PANS pediatric — immunology / rheumatology / neurology follow-up; deep brain stimulation referral for severe refractory (>5 years duration, multiple failed treatments) per IOCDF 2025; TMS evolving evidence per IOCDF 2025

6. Sources

Guideline: APA Practice Guideline for OCD — Koran AJP 2007 + 2013 watch reaffirmation + 2023 update (PMID 18923524) + NICE CG31 2024 surveillance refresh + IOCDF 2025 consensus + PANS Consortium Frankovich JCAP 2017 PMID 28859386 + 2024 update + AACAP 2012 OCD parameter (pediatric)

  1. pubmed.ncbi.nlm.nih.gov/2684084
  2. pubmed.ncbi.nlm.nih.gov/1671693
  3. pubmed.ncbi.nlm.nih.gov/18923524